The interrelationships between serum 25-hydroxycholecalciferol, serum parathyroid hormone and bone changes in anticonvulsant osteomalacia

Acta Endocrinol (Copenh). 1977 Mar;84(3):559-65. doi: 10.1530/acta.0.0840559.

Abstract

Serum 25-hydroxycholecalciferol (25-HCC) and serum parathyroid hormone (iPTH) were measured in 59 randomly selected adult epileptic outpatients receiving chronic anticonvulsant therapy. Quantitative morphometric analysis of iliac crest biopsies was performed. A mild degree of osteomalacia was found which was inversely correlated to dietary vitamin D intake. Serum 25-HCC was reduced in the epileptic patients compared to a control group, although dietary intake of vitamin D was higher than the mean daily intake in the Danish population. Serum 25-HCC was positively correlated to dietary vitamin D intake, but not correlated to the severity of bone changes, indicating that other factors than circulating 25-HCC are responsible for the development of anticonvulsant osteomalacia. Serum 25-HCG was inversely correlated to serum iPTH in patients with a low dietary calcium intake. The mean value of serum iPTH was not increased, and there was no correlation between serum iPTH and bone morphometry.

MeSH terms

  • Adolescent
  • Adult
  • Binding, Competitive
  • Calcium, Dietary
  • Epilepsy / blood
  • Epilepsy / drug therapy
  • Feeding Behavior
  • Female
  • Humans
  • Hydroxycholecalciferols / blood*
  • Male
  • Middle Aged
  • Osteomalacia / blood
  • Osteomalacia / chemically induced*
  • Parathyroid Hormone / blood*
  • Phenytoin / adverse effects*
  • Phenytoin / therapeutic use
  • Vitamin D

Substances

  • Calcium, Dietary
  • Hydroxycholecalciferols
  • Parathyroid Hormone
  • Vitamin D
  • Phenytoin